Home > Insider Trading > Filing (0001209191-10-058266)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1003642	Impax Laboratories Inc	IPXL	Pharmaceutical Preparations (2834)	650403311

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1245186	Z Leslie Benet	C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2010-12-01	4,000	$8.00	7,000	No	4	M	Direct
Common Stock	Acquisiton	2010-12-01	10,000	$6.55	17,000	No	4	M	Direct
Common Stock	Disposition	2010-12-01	10,000	$18.10	7,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2010-12-01	4,000	$0.00	4,000	$8.00
Common Stock	Stock Option (Right to Buy)	Disposition	2010-12-01	10,000	$0.00	10,000	$6.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,500		2013-05-16	No	4	M	Direct
65,000		2019-05-20	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	600	Indirect	The Benet Family Trust

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.08 to $18.12. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option, representing a right to purchase a total of 7,500 shares, became exercisable in three equal annual installments beginning on May 16, 2004, which was the first anniversary of the date on which the option was granted.
The option, representing a right to purchase a total of 75,000 shares, becomes exercisable in three equal annual installments beginning on May 20, 2010, which was the first anniversary of the date on which the option was granted.